Glory Health Industry Limited (HKG:2329)
Hong Kong
· Delayed Price · Currency is HKD 0.0980
+0.0060 (6.52%)
Apr 30, 2026, 11:44 AM HKT
Glory Health Industry Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,036 | 2,705 | 2,506 | 3,905 | 9,898 | Upgrade
|
| Revenue Growth (YoY) | -61.72% | 7.94% | -35.81% | -60.55% | 71.58% | Upgrade
|
| Cost of Revenue | 1,344 | 2,150 | 2,557 | 3,791 | 8,651 | Upgrade
|
| Gross Profit | -308.09 | 555.56 | -50.28 | 113.52 | 1,247 | Upgrade
|
| Selling, General & Admin | 243.61 | 277.35 | 406.71 | 460.57 | 667.52 | Upgrade
|
| Operating Expenses | 462.74 | 308.87 | 411.13 | 528.65 | 751.22 | Upgrade
|
| Operating Income | -770.83 | 246.7 | -461.41 | -415.14 | 496.02 | Upgrade
|
| Interest Expense | -783.78 | -1,004 | -502.67 | -451.59 | -744.91 | Upgrade
|
| Interest & Investment Income | 0.24 | 65.58 | 73.56 | 74.26 | 83.94 | Upgrade
|
| Earnings From Equity Investments | - | -69.93 | -72.56 | 42.03 | 166.39 | Upgrade
|
| Currency Exchange Gain (Loss) | 61.88 | -13.72 | -18.76 | -350.02 | 444.53 | Upgrade
|
| Other Non Operating Income (Expenses) | -101.4 | -86.58 | -24.29 | -0.66 | 24.86 | Upgrade
|
| EBT Excluding Unusual Items | -1,594 | -861.63 | -1,006 | -1,101 | 470.82 | Upgrade
|
| Gain (Loss) on Sale of Assets | -799.71 | -17.72 | 146.12 | 2.45 | 332.01 | Upgrade
|
| Asset Writedown | 47.88 | -498.94 | 263.5 | 20.06 | 115.7 | Upgrade
|
| Other Unusual Items | 444.08 | -58.03 | -58.95 | -11.75 | -41.66 | Upgrade
|
| Pretax Income | -1,902 | -1,436 | -655.46 | -1,090 | 876.87 | Upgrade
|
| Income Tax Expense | -132.24 | -20.81 | -61.96 | -95.05 | 532.35 | Upgrade
|
| Earnings From Continuing Operations | -1,769 | -1,416 | -593.5 | -995.29 | 344.52 | Upgrade
|
| Minority Interest in Earnings | -53.09 | 175.07 | 29.53 | 82.51 | -116.18 | Upgrade
|
| Net Income | -1,822 | -1,240 | -563.97 | -912.78 | 228.33 | Upgrade
|
| Net Income to Common | -1,822 | -1,240 | -563.97 | -912.78 | 228.33 | Upgrade
|
| Net Income Growth | - | - | - | - | 131.25% | Upgrade
|
| Shares Outstanding (Basic) | 4,444 | 4,444 | 4,444 | 4,444 | 4,444 | Upgrade
|
| Shares Outstanding (Diluted) | 4,444 | 4,444 | 4,444 | 4,444 | 4,444 | Upgrade
|
| EPS (Basic) | -0.41 | -0.28 | -0.13 | -0.21 | 0.05 | Upgrade
|
| EPS (Diluted) | -0.41 | -0.28 | -0.13 | -0.21 | 0.05 | Upgrade
|
| EPS Growth | - | - | - | - | 131.42% | Upgrade
|
| Free Cash Flow | - | 678.26 | 452.11 | 413.47 | 4,066 | Upgrade
|
| Free Cash Flow Per Share | - | 0.15 | 0.10 | 0.09 | 0.92 | Upgrade
|
| Gross Margin | -29.75% | 20.54% | -2.01% | 2.91% | 12.60% | Upgrade
|
| Operating Margin | -74.43% | 9.12% | -18.41% | -10.63% | 5.01% | Upgrade
|
| Profit Margin | -175.98% | -45.85% | -22.50% | -23.38% | 2.31% | Upgrade
|
| Free Cash Flow Margin | - | 25.07% | 18.04% | 10.59% | 41.08% | Upgrade
|
| EBITDA | -696.9 | 320.62 | -384.83 | -325.93 | 581.55 | Upgrade
|
| EBITDA Margin | -67.29% | 11.85% | -15.35% | -8.35% | 5.88% | Upgrade
|
| D&A For EBITDA | 73.93 | 73.93 | 76.58 | 89.2 | 85.53 | Upgrade
|
| EBIT | -770.83 | 246.7 | -461.41 | -415.14 | 496.02 | Upgrade
|
| EBIT Margin | -74.43% | 9.12% | -18.41% | -10.63% | 5.01% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 60.71% | Upgrade
|
| Revenue as Reported | 1,036 | 2,705 | 2,506 | 3,905 | 9,898 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.